T2DM (Type 2 Diabetes Mellitus)

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Virtual Diabetes Group Visits Across Health Systems

Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease

Anti-inflammatory Dietary Intervention in Patients With Type 2 Diabetes: A Randomized Controlled Trial

A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus

Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes

A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease

Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

Detecting Type 2 Diabetes From Voice

Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type 2 Diabetes Mellitus

Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients

GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine